Literature DB >> 6938188

Mitochondrial myopathy with cardiomyopathy, lactic acidosis and response to prednisone and thiamine.

F L Mastaglia, P L Thompson, J M Papadimitriou.   

Abstract

Clinical, biochemical and pathological findings are described in a 23-year-old male with a mitochondrial myopathy who had a high-output circulatory state and cardiomyopathy which resulted in cardiac insufficiency 22 years before presentation of the skeletal myopathy. Venous lactate levels were elevated and severe lactic acidosis developed at one stage of the illness. Electron microscopy of muscle tissue showed various mitochondrial abnormalities and accumulation of neutral lipids which was confirmed histochemically and by thin-layer chromatography. Marked improvement in the myopathy occurred after commencement of prednisone and thiamine and was maintained following withdrawal of these drugs. The metabolic defect in this case has not been defined, but an abnormality in the Kreb's over-production of lactate and lipid accumulation in muscle is postulated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6938188     DOI: 10.1111/j.1445-5994.1980.tb04250.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  9 in total

1.  Glucocorticoids for mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 2.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

4.  Hypertrophic cardiomyopathy associated with a mitochondrial myopathy of voluntary muscles and congenital cataract.

Authors:  R C Sengers; A M Stadhouders; E van Lakwijk-Vondrovicova; K Kubat; W Ruitenbeek
Journal:  Br Heart J       Date:  1985-11

5.  Cardiomyopathy in the Kearns-Sayre syndrome.

Authors:  K S Channer; J L Channer; M J Campbell; J R Rees
Journal:  Br Heart J       Date:  1988-04

6.  Mitochondrial encephalomyopathy. A variant with heart failure and liver steatosis.

Authors:  A Oldfors; M Tulinius; E Holme; H Kalimo; B Kristiansson; B O Eriksson
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  omega-123I-hexadecanoic acid metabolic probe of cardiomyopathy.

Authors:  M A Rabinovitch; V Kalff; R Allen; A Rosenthal; J Albers; S K Das; B Pitt; D P Swanson; T Mangner; W L Rogers
Journal:  Eur J Nucl Med       Date:  1985

8.  Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET).

Authors:  L Nashef; R J Lane
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

Review 9.  The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.

Authors:  Allison Hanaford; Simon C Johnson
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.